| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
449,967 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$81,866,696 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
69 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baker Felix |
Director |
– • • |
2006-06-22 |
4 |
B |
$4.05 |
$94,256 |
I/I |
23,244 |
3,188,435 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-22 |
4 |
B |
$4.05 |
$2,036 |
I/I |
502 |
73,865 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-21 |
4 |
B |
$4.07 |
$150,643 |
I/I |
36,983 |
3,165,191 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-21 |
4 |
B |
$4.07 |
$3,246 |
I/I |
797 |
73,363 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-21 |
4 |
B |
$4.07 |
$49,776 |
I/I |
12,220 |
1,212,541 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-20 |
4 |
B |
$3.99 |
$194,796 |
I/I |
48,776 |
3,128,208 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-20 |
4 |
B |
$3.99 |
$4,201 |
I/I |
1,052 |
72,566 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-20 |
4 |
B |
$3.99 |
$64,366 |
I/I |
16,117 |
1,200,321 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-19 |
4 |
B |
$4.00 |
$119,708 |
I/I |
29,946 |
3,079,432 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-19 |
4 |
B |
$4.00 |
$2,578 |
I/I |
645 |
71,514 |
2.17 |
- |
|
| Baker Felix |
Director |
– • • |
2006-06-19 |
4 |
B |
$4.00 |
$39,555 |
I/I |
9,895 |
1,184,204 |
2.25 |
- |
|
| Baker Felix |
Director |
– • – |
2006-06-13 |
4 |
B |
$3.90 |
$7,526 |
I/I |
1,881 |
70,869 |
2.1 |
- |
|
| Baker Felix |
Director |
– • – |
2006-06-13 |
4 |
B |
$3.90 |
$115,329 |
I/I |
28,825 |
1,174,309 |
2.1 |
- |
|
| Baker Felix |
Director |
– • – |
2006-06-13 |
4 |
B |
$3.90 |
$349,031 |
I/I |
87,236 |
3,049,486 |
2.1 |
- |
|
| Baker Felix |
Director |
– • – |
2006-06-09 |
4 |
B |
$4.00 |
$124,916 |
I/I |
31,197 |
68,988 |
2.1 |
- |
|
| Baker Felix |
Director |
– • – |
2006-06-09 |
4 |
B |
$4.00 |
$1,914,744 |
I/I |
478,196 |
1,145,484 |
2.1 |
- |
|
| Baker Felix |
Director |
– • – |
2006-06-09 |
4 |
B |
$4.00 |
$5,794,759 |
I/I |
1,447,207 |
2,962,250 |
2.1 |
- |
|
| Baker Felix |
Director |
– • • |
2006-05-24 |
4 |
B |
$5.25 |
$4,368,709 |
I/I |
832,135 |
1,515,043 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-05-24 |
4 |
B |
$5.25 |
$95,708 |
I/I |
18,230 |
37,791 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2006-05-24 |
4 |
B |
$5.25 |
$1,462,913 |
I/I |
278,650 |
667,288 |
2.25 |
- |
|
| Trailsmith Pamela A |
Chief Scientific OfficerOffice |
• – – |
2006-05-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,100 |
|
- |
|
| Gryska David W |
Director |
– • – |
2006-05-09 |
4 |
A |
$4.59 |
$11,484 |
D/D |
2,500 |
7,500 |
|
- |
|
| Baker Felix |
Director |
– • • |
2006-04-25 |
4 |
A |
$0.00 |
$0 |
I/I |
448,047 |
682,908 |
|
- |
|
| Baker Felix |
Director |
– • • |
2006-04-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(448,047) |
0 |
|
- |
|
| Gryska David W |
Director |
– • – |
2006-02-14 |
4 |
A |
$4.90 |
$24,574 |
D/D |
5,000 |
5,000 |
|
- |
|
1805 Records found
|
|
Page 64 of 73 |
|
|
